サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386212

頭蓋咽頭腫治療の世界市場：動向、予測、競合分析（～2030年）

Craniopharyngioma Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

頭蓋咽頭腫治療の世界市場：動向、予測、競合分析（～2030年）
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

頭蓋咽頭腫治療の動向と予測

世界の頭蓋咽頭腫治療の市場規模は、2024～2030年にかけてCAGR 7.1％で成長し、2030年までに約2,000万米ドルに達すると予測されています。この市場の主な促進要因は、世界中で脳腫瘍の罹患率が増加していること、ヘルスケア支出が増加していること、画像技術、放射線療法、手術技術が進歩し続けていることです。世界の頭蓋咽頭腫治療市場の将来は、病院、診療所、外来手術センター、がん研究機関、診断研究所の各市場における機会によって有望視されています。

頭蓋咽頭腫治療市場の洞察

Lucintelでは、磁気共鳴画像法（MRI）は脳と下垂体の詳細な画像を作成できることから、予測期間中も最大セグメントであり続けると予測しています。

この市場の中では、病院が提供する施設、高度に熟練したヘルスケア専門家の利用可能性、最先端の医療技術の存在により、病院が最大セグメントであり続けると思われます。

北米は、頭蓋咽頭腫の有病率の増加、高度なヘルスケアインフラの存在、および同地域における有利な償還政策により、予測期間中も最大セグメントであり続けると思われます。

市場規模・推計：頭蓋咽頭腫治療の市場規模を金額（10億米ドル）で推計

動向と予測分析：各種セグメント別、地域別の市場動向（2018～2023年）と予測（2024～2030年）

セグメンテーション分析：頭蓋咽頭腫治療市場規模を診断、治療、最終用途産業、地域別に金額（10億米ドル）で推計

地域別分析：頭蓋咽頭腫治療市場の北米、欧州、アジア太平洋、その他の地域内訳

成長機会：頭蓋咽頭腫治療市場の診断、治療、最終用途産業、地域別の成長機会の分析

戦略分析：頭蓋咽頭腫治療市場のM&A、新製品開発、競合情勢など

ポーターのファイブフォースモデルに基づく業界の競合強度分析

本レポートは以下の11の主要な質問に回答しています：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の頭蓋咽頭腫治療市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 市場動向と予測分析：2018～2030年

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の頭蓋咽頭腫治療市場の動向（2018～2023年）と予測（2024～2030年）
  • 世界の頭蓋咽頭腫治療市場：診断別
    • 磁気共鳴画像法（MRI）
    • コンピュータ断層撮影（CT）
    • 生検
    • 血液検査
    • ホルモン検査
  • 世界の頭蓋咽頭腫治療市場：治療別
    • 手術
    • 放射線治療
    • 化学療法
    • 標的療法
    • ホルモン補充療法
  • 世界の頭蓋咽頭腫治療市場：最終用途産業別
    • 病院
    • クリニック
    • 外来手術センター
    • がん調査
    • 診断研究所
    • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

  • 世界の頭蓋咽頭腫治療市場：地域別
  • 北米の頭蓋咽頭腫治療市場
  • 欧州の頭蓋咽頭腫治療市場
  • アジア太平洋の頭蓋咽頭腫治療市場
  • その他の地域の頭蓋咽頭腫治療市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 診断別の世界の頭蓋咽頭腫治療市場の成長機会
    • 治療別の世界の頭蓋咽頭腫治療市場の成長機会
    • 最終用途産業別の世界の頭蓋咽頭腫治療市場の成長機会
    • 地域別の世界の頭蓋咽頭腫治療市場の成長機会
  • 世界の頭蓋咽頭腫治療市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の頭蓋咽頭腫治療市場の能力拡大
    • 世界の頭蓋咽頭腫治療市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Pfizer
  • Novartis
  • Merck
  • Kazia Therapeutics
  • AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Ipsen Biopharmaceuticals
  • Johnson & Johnson
目次

Craniopharyngioma Treatment Trends and Forecast

The future of the global craniopharyngioma treatment market looks promising with opportunities in the hospital, clinic, ambulatory surgical center, cancer research institute, and diagnostic laboratory markets. The global craniopharyngioma treatment market is expected to reach an estimated $0.02 billion by 2030 with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are the increasing incidence of brain cancer across the globe, growing healthcare expenditure, and on-going advancement in imaging technology, radiation therapy, and surgical techniques.

A more than 150-page report is developed to help in your business decisions.

Craniopharyngioma Treatment by Segment

The study includes a forecast for the global craniopharyngioma treatment by diagnosis, treatment, end use industry, and region.

Craniopharyngioma Treatment Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Biopsy
  • Biopsy
  • Hormone Tests

Craniopharyngioma Treatment Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Surgery
  • Radiation Therapy
  • Chemotherapy
  • Targeted Therapy
  • Hormone Replacement Therapy

Craniopharyngioma Treatment Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
  • Diagnostic Laboratories
  • Others

Craniopharyngioma Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Craniopharyngioma Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies craniopharyngioma treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the craniopharyngioma treatment companies profiled in this report include-

  • Pfizer
  • Novartis
  • Merck
  • Kazia Therapeutics
  • Abbvie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Ipsen Biopharmaceuticals
  • Johnson & Johnson

Craniopharyngioma Treatment Market Insights

Lucintel forecasts that magnetic resonance imaging (MRI) will remain the largest segment over the forecast period due to its ability to develop detailed images of the brain and pituitary gland.

Within this market, hospital will remain the largest segment due to the facilities provided by hospitals, availability of highly skilled healthcare professionals, and presence of cutting-edge medical technology.

North America will remain the largest segment over the forecast period due to the increasing prevalence of craniopharyngioma, presence of advanced healthcare infrastructure, and favorable reimbursement policies in the region.

Features of the Global Craniopharyngioma Treatment Market

Market Size Estimates: Craniopharyngioma treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Craniopharyngioma treatment market size by diagnosis, treatment, end use industry, and region in terms of value ($B).

Regional Analysis: Craniopharyngioma treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnosis, treatment, end use industries, and regions for the craniopharyngioma treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the craniopharyngioma treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the craniopharyngioma treatment market size?

Answer: The global craniopharyngioma treatment market is expected to reach an estimated $0.02 billion by 2030.

Q.2 What is the growth forecast for craniopharyngioma treatment market?

Answer: The global craniopharyngioma treatment market is expected to grow with a CAGR of 7.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the craniopharyngioma treatment market?

Answer: The major drivers for this market are the increasing incidence of brain cancer across the globe, growing healthcare expenditure, and on-going advancement in imaging technology, radiation therapy, and surgical techniques.

Q4. What are the major segments for craniopharyngioma treatment market?

Answer: The future of the craniopharyngioma treatment market looks promising with opportunities in the hospital, clinic, ambulatory surgical center, cancer research institute, and diagnostic laboratory markets.

Q5. Who are the key craniopharyngioma treatment market companies?

Answer: Some of the key craniopharyngioma treatment companies are as follows:

  • Pfizer
  • Novartis
  • Merck
  • Kazia Therapeutics
  • AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Ipsen Biopharmaceuticals
  • Johnson & Johnson

Q6. Which craniopharyngioma treatment market segment will be the largest in future?

Answer: Lucintel forecasts that magnetic resonance imaging (MRI) will remain the largest segment over the forecast period due to its ability to develop detailed images of the brain and pituitary gland.

Q7. In craniopharyngioma treatment market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest segment over the forecast period due to the increasing prevalence of craniopharyngioma, presence of advanced healthcare infrastructure, and favorable reimbursement policies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the craniopharyngioma treatment market by diagnosis (magnetic resonance imaging (MRI), computed tomography (CT), biopsy,blood tests, and hormone tests), treatment (surgery, radiation therapy, chemotherapy, targeted therapy, and hormone replacement therapy), end use industry (hospitals, clinics, ambulatory surgical centers, cancer research institutes, diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Craniopharyngioma Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Craniopharyngioma Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Craniopharyngioma Treatment Market by Diagnosis
    • 3.3.1: Magnetic Resonance Imaging (MRI)
    • 3.3.2: Computed Tomography (CT)
    • 3.3.3: Biopsy
    • 3.3.4: Blood Tests
    • 3.3.5: Hormone Tests
  • 3.4: Global Craniopharyngioma Treatment Market by Treatment
    • 3.4.1: Surgery
    • 3.4.2: Radiation Therapy
    • 3.4.3: Chemotherapy
    • 3.4.4: Targeted Therapy
    • 3.4.5: Hormone Replacement Therapy
  • 3.5: Global Craniopharyngioma Treatment Market by End Use Industry
    • 3.5.1: Hospitals
    • 3.5.2: Clinics
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Cancer Research Institutes
    • 3.5.5: Diagnostic Laboratories
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Craniopharyngioma Treatment Market by Region
  • 4.2: North American Craniopharyngioma Treatment Market
    • 4.2.2: North American Craniopharyngioma Treatment Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Laboratories, and Others
  • 4.3: European Craniopharyngioma Treatment Market
    • 4.3.1: European Craniopharyngioma Treatment Market by Diagnosis: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Biopsy, Blood Tests, and Hormone Tests
    • 4.3.2: European Craniopharyngioma Treatment Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Laboratories, and Others
  • 4.4: APAC Craniopharyngioma Treatment Market
    • 4.4.1: APAC Craniopharyngioma Treatment Market by Diagnosis: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Biopsy, Blood Tests, and Hormone Tests
    • 4.4.2: APAC Craniopharyngioma Treatment Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Laboratories, and Others
  • 4.5: ROW Craniopharyngioma Treatment Market
    • 4.5.1: ROW Craniopharyngioma Treatment Market by Diagnosis: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Biopsy, Blood Tests, and Hormone Tests
    • 4.5.2: ROW Craniopharyngioma Treatment Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, Cancer Research Institutes, Diagnostic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Craniopharyngioma Treatment Market by Diagnosis
    • 6.1.2: Growth Opportunities for the Global Craniopharyngioma Treatment Market by Treatment
    • 6.1.3: Growth Opportunities for the Global Craniopharyngioma Treatment Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Craniopharyngioma Treatment Market by Region
  • 6.2: Emerging Trends in the Global Craniopharyngioma Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Craniopharyngioma Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Craniopharyngioma Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer
  • 7.2: Novartis
  • 7.3: Merck
  • 7.4: Kazia Therapeutics
  • 7.5: AbbVie
  • 7.6: Bristol-Myers Squibb
  • 7.7: F. Hoffmann-La Roche
  • 7.8: Ipsen Biopharmaceuticals
  • 7.9: Johnson & Johnson